ArticleCancer chemotherapy and pharmacology2018

Exposure-response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer.

Peter N Morcos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.